Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Systemic Lupus Erythematosus |
📓
Altered Profile of Fecal Microbiota in Newly Diagnosed Systemic Lupus Erythematosus Egyptian Patients. International journal of microbiology (Int J Microbiol ) Vol: 2021 Issue Pages: 9934533 Pub: 2021 Epub: 2021 Jun 24 Authors Gerges MA , Esmaeel NE , Makram WK , Sharaf DM , Gebriel MG , Html Article Publication |
| Systemic Lupus Erythematosus |
📓
Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut microbes (Gut Microbes ) Vol: 11 Issue 6 Pages: 1758-1773 Pub: 2020 Nov 1 Epub: 2020 Jun 7 Authors Guo M , Wang H , Xu S , Zhuang Y , An J , Su C , Xia Y , Chen J , Xu ZZ , Liu Q , Wang J , Dan Z , Chen K , Luan X , Liu Z , Liu K , Zhang F , Xia Y , Liu X , Html Article Publication |
| Systemic Lupus Erythematosus |
📓
Microbiome and Metabolome Analyses Reveal the Disruption of Lipid Metabolism in Systemic Lupus Erythematosus. Frontiers in immunology (Front Immunol ) Vol: 11 Issue Pages: 1703 Pub: 2020 Epub: 2020 Jul 31 Authors He J , Chan T , Hong X , Zheng F , Zhu C , Yin L , Dai W , Tang D , Liu D , Dai Y , Html Article Publication |
| Systemic Lupus Erythematosus |
📓
Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal. Annals of the rheumatic diseases (Ann Rheum Dis ) Vol: 78 Issue 7 Pages: 947-956 Pub: 2019 Jul Epub: 2019 Feb 19 Authors Azzouz D , Omarbekova A , Heguy A , Schwudke D , Gisch N , Rovin BH , Caricchio R , Buyon JP , Alekseyenko AV , Silverman GJ , Html Article Publication |
| Systemic Lupus Erythematosus |
📓
Changes of intestinal flora in patients with systemic lupus erythematosus in northeast China. PloS one (PLoS One ) Vol: 14 Issue 3 Pages: e0213063 Pub: 2019 Epub: 2019 Mar 14 Authors Wei F , Xu H , Yan C , Rong C , Liu B , Zhou H , Html Article Publication |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
